Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report

Introduction Hepatic insulin clearance (HIC) is an important pathophysiology of type 2 diabetes. HIC was reported to decrease in patients with type 2 diabetes and metabolic syndrome. However, hyperglycemia was suggested to enhance HIC, and it is not known whether poorly controlled diabetes increases...

Full description

Bibliographic Details
Main Authors: Hisashi Noma, Tsuyoshi Okura, Yohei Fujioka, Risa Nakamura, Mari Anno, Yuichi Ito, Sonoko Kitao, Kazuhisa Matsumoto, Kyoko Shoji, Keisuke Sumi, Kazuhiko Matsuzawa, Shoichiro Izawa, Hiroko Okura, Etsuko Ueta, Masahiko Kato, Takeshi Imamura, Shin-Ichi Taniguchi, Kazuhiro Yamamoto
Format: Article
Language:English
Published: BMJ Publishing Group 2020-04-01
Series:BMJ Open Diabetes Research & Care
Online Access:https://drc.bmj.com/content/8/1/e001149.full
id doaj-25ae4404afab4fd5a3d99eab60086ab1
record_format Article
spelling doaj-25ae4404afab4fd5a3d99eab60086ab12021-06-10T10:04:41ZengBMJ Publishing GroupBMJ Open Diabetes Research & Care2052-48972020-04-018110.1136/bmjdrc-2019-001149Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary reportHisashi Noma0Tsuyoshi OkuraYohei FujiokaRisa NakamuraMari AnnoYuichi ItoSonoko KitaoKazuhisa MatsumotoKyoko ShojiKeisuke SumiKazuhiko MatsuzawaShoichiro IzawaHiroko OkuraEtsuko UetaMasahiko KatoTakeshi ImamuraShin-Ichi TaniguchiKazuhiro Yamamoto13 Department of Data Science, The Institute of Statistical Mathematics, Tokyo, Japan 3Division of Cardiolovascular Medicine, Department of Molecular Medicine and Therapeutics, Tottori University, Yonago, JapanIntroduction Hepatic insulin clearance (HIC) is an important pathophysiology of type 2 diabetes. HIC was reported to decrease in patients with type 2 diabetes and metabolic syndrome. However, hyperglycemia was suggested to enhance HIC, and it is not known whether poorly controlled diabetes increases HIC in patients with type 2 diabetes. We investigated whether HIC was increased in patients with poorly controlled diabetes, and whether HIC was associated with insulin resistance and incretins.Research design and methods We performed a meal tolerance test and the hyperinsulinemic–euglycemic clamp in 21 patients with type 2 diabetes. We calculated the postprandial C-peptide area under the curve (AUC)-to-insulin AUC ratio as the HIC; measured fasting and postprandial glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and glucagon levels and analyzed serum adiponectin and zinc transporter-8 (ZnT8) gene polymorphism.Results The HIC significantly correlated with glycated hemoglobin (HbA1c) (r_S=0.58, p<0.01). In patients with high HIC above the median of 6.5, the mean HbA1c was significantly higher compared with low HIC below the median. Homeostatic model assessment (HOMA)-beta (r_S=−0.77, p<0.01) and HOMA-IR (r_S=−0.66, p<0.005) were correlated with HIC. The M/I value in the clamp study was correlated with HIC. GLP-1-AUC and GIP-AUC were not correlated with HIC. Glucagon-AUC was negatively correlated with HIC, but there were no significant differences between the high and low HIC groups. Adiponectin was positively correlated with HIC. The ZnT8 gene polymorphism did not affect HIC.Conclusions These results suggest that HIC was increased in patients with high HbA1c type 2 diabetes, low insulin secretion, low insulin resistance and high adiponectin conditions.https://drc.bmj.com/content/8/1/e001149.full
collection DOAJ
language English
format Article
sources DOAJ
author Hisashi Noma
Tsuyoshi Okura
Yohei Fujioka
Risa Nakamura
Mari Anno
Yuichi Ito
Sonoko Kitao
Kazuhisa Matsumoto
Kyoko Shoji
Keisuke Sumi
Kazuhiko Matsuzawa
Shoichiro Izawa
Hiroko Okura
Etsuko Ueta
Masahiko Kato
Takeshi Imamura
Shin-Ichi Taniguchi
Kazuhiro Yamamoto
spellingShingle Hisashi Noma
Tsuyoshi Okura
Yohei Fujioka
Risa Nakamura
Mari Anno
Yuichi Ito
Sonoko Kitao
Kazuhisa Matsumoto
Kyoko Shoji
Keisuke Sumi
Kazuhiko Matsuzawa
Shoichiro Izawa
Hiroko Okura
Etsuko Ueta
Masahiko Kato
Takeshi Imamura
Shin-Ichi Taniguchi
Kazuhiro Yamamoto
Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report
BMJ Open Diabetes Research & Care
author_facet Hisashi Noma
Tsuyoshi Okura
Yohei Fujioka
Risa Nakamura
Mari Anno
Yuichi Ito
Sonoko Kitao
Kazuhisa Matsumoto
Kyoko Shoji
Keisuke Sumi
Kazuhiko Matsuzawa
Shoichiro Izawa
Hiroko Okura
Etsuko Ueta
Masahiko Kato
Takeshi Imamura
Shin-Ichi Taniguchi
Kazuhiro Yamamoto
author_sort Hisashi Noma
title Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report
title_short Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report
title_full Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report
title_fullStr Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report
title_full_unstemmed Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report
title_sort hepatic insulin clearance is increased in patients with high hba1c type 2 diabetes: a preliminary report
publisher BMJ Publishing Group
series BMJ Open Diabetes Research & Care
issn 2052-4897
publishDate 2020-04-01
description Introduction Hepatic insulin clearance (HIC) is an important pathophysiology of type 2 diabetes. HIC was reported to decrease in patients with type 2 diabetes and metabolic syndrome. However, hyperglycemia was suggested to enhance HIC, and it is not known whether poorly controlled diabetes increases HIC in patients with type 2 diabetes. We investigated whether HIC was increased in patients with poorly controlled diabetes, and whether HIC was associated with insulin resistance and incretins.Research design and methods We performed a meal tolerance test and the hyperinsulinemic–euglycemic clamp in 21 patients with type 2 diabetes. We calculated the postprandial C-peptide area under the curve (AUC)-to-insulin AUC ratio as the HIC; measured fasting and postprandial glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and glucagon levels and analyzed serum adiponectin and zinc transporter-8 (ZnT8) gene polymorphism.Results The HIC significantly correlated with glycated hemoglobin (HbA1c) (r_S=0.58, p<0.01). In patients with high HIC above the median of 6.5, the mean HbA1c was significantly higher compared with low HIC below the median. Homeostatic model assessment (HOMA)-beta (r_S=−0.77, p<0.01) and HOMA-IR (r_S=−0.66, p<0.005) were correlated with HIC. The M/I value in the clamp study was correlated with HIC. GLP-1-AUC and GIP-AUC were not correlated with HIC. Glucagon-AUC was negatively correlated with HIC, but there were no significant differences between the high and low HIC groups. Adiponectin was positively correlated with HIC. The ZnT8 gene polymorphism did not affect HIC.Conclusions These results suggest that HIC was increased in patients with high HbA1c type 2 diabetes, low insulin secretion, low insulin resistance and high adiponectin conditions.
url https://drc.bmj.com/content/8/1/e001149.full
work_keys_str_mv AT hisashinoma hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport
AT tsuyoshiokura hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport
AT yoheifujioka hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport
AT risanakamura hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport
AT marianno hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport
AT yuichiito hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport
AT sonokokitao hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport
AT kazuhisamatsumoto hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport
AT kyokoshoji hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport
AT keisukesumi hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport
AT kazuhikomatsuzawa hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport
AT shoichiroizawa hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport
AT hirokookura hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport
AT etsukoueta hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport
AT masahikokato hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport
AT takeshiimamura hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport
AT shinichitaniguchi hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport
AT kazuhiroyamamoto hepaticinsulinclearanceisincreasedinpatientswithhighhba1ctype2diabetesapreliminaryreport
_version_ 1721385117091364864